The Laboratory collaborates with the following institutes by providing them with cell lines established from patients at PMH.

This is done by growing the patient’s cancer cells in test tubes:


  • The Sanger Centre, Hinxton, England
  • Medical Research Council, Cambridge, England.
  • Institute of Cancer Research, Sutton, England.
  • Leukaemia Research Fund Centre, Royal Cancer Hospital, London
  • University of Cambridge, England
  • University of Surrey, England
  • University of Newcastle upon Tyne, Newcastle upon Tyne, England
  • The Netherlands Cancer Institute, The Netherlands
  • Institute of Genetics & Molecular Biology, Strasbourg, France
  • University La Laguna, Tenerife, Spain
  • Harvard Medical School, MA USA
  • Children’s Hospital of Philadelphia, PA USA
  • Ohio State University, Columbus, OH USA
  • National Human Genome Research Institute, Bethesda, MD USA



  • Roswell Park Cancer Institute, Buffalo, NY USA
  • University of North Carolina, Chapel Hill, USA
  • University of Southern California, USA
  • DNAX Research Institute, Palo Alto, USA
  • University of California, Los Angeles, USA
  • University of Chicago, Chicago, IL USA
  • The Children’s National Medical Center, Washington, DC USA
  • National Human Genome Research Institute, NIH, Bethesda, MD USA


New Zealand

  • Canterbury Health Labs, Christchurch, New Zealand



  • Kobe University, Japan



  • Victorian Cancer Cytogenetic Service, St. Vincent’s Hospital Melbourne
  • Women’s and Children’s Hospital, Adelaide
  • Peter MacCallum Institute, Melbourne
  • Sydney Children’s Hospital, Sydney
  • Westmead Hospital, Sydney
  • Royal Brisbane Hospital, Brisbane
  • Queensland Institute of Medical Research, Brisbane
  • Institute of Medical and Veterinary Science, Adelaide
  • Princess Margaret Hospital for Children, Perth
  • WA Centre for Pathology and Medical Research, Perth
  • Royal Perth Hospital, Perth
  • QEII Medical Centre, Perth
  • King Edward Memorial Hospital, Perth
  • Dept. Biochemistry, University of WA, Perth


Collaboration on genetic markers (error in genetic materials in cancer cells only) and treatment of leukaemia:

  • Children’s Oncology Group, Los Angeles, USA